Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pharming Group has concluded a license agreement with Advanced Cell Technology to obtain exclusive rights on patents in the field of transgenic technology, to which it already had non-exclusive rights.
Subscribe to our email newsletter
These patents were previously owned by Infigen and cover a wide range of technologies including for Pharming relevant elements of nuclear transfer, which is an essential step in generating transgenic cattle.
The agreement provides Pharming strict control over the generation of its transgenic cattle, while, at the same time, increasing the barriers of entry for others.